<VariationArchive VariationID="3246930" VariationName="NC_000003.11:g.(?_69058895)_(69061253_?)del" VariationType="Deletion" Accession="VCV003246930" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-07" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3406950" VariationID="3246930">
      <GeneList>
        <Gene Symbol="EOGT" FullName="EGF domain specific O-linked N-acetylglucosamine transferase" GeneID="285203" HGNC_ID="HGNC:28526" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="68975225" stop="69013684" display_start="68975225" display_stop="69013684" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="69024367" stop="69062773" display_start="69024367" display_stop="69062773" Strand="-" />
          </Location>
          <OMIM>614789</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000003.11:g.(?_69058895)_(69061253_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" innerStart="69058895" innerStop="69061253" display_start="69058895" display_stop="69061253" variantLength="2359" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.(?_69058895)_(69061253_?)del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.(?_69058895)_(69061253_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000003.11:g.(?_69058895)_(69061253_?)del AND Adams-Oliver syndrome 4" Accession="RCV004582216" Version="1">
        <ClassifiedConditionList TraitSetID="10612">
          <ClassifiedCondition DB="MedGen" ID="C3809092">Adams-Oliver syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-06-30" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23522784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23860037</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10612" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17952" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adams-Oliver syndrome 4</ElementValue>
                <XRef ID="MONDO:0014124" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AOS4</ElementValue>
                <XRef Type="MIM" ID="615297" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15941" />
                <XRef ID="15941" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Adams-Oliver syndrome (AOS) is characterized by aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD). ACC lesions usually occur in the midline of the parietal or occipital regions, but can also occur on the abdomen or limbs. At birth, an ACC lesion may already have the appearance of a healed scar. ACC lesions less than 5 cm often involve only the skin and almost always heal over a period of months; larger lesions are more likely to involve the skull and possibly the dura, and are at greater risk for complications, which can include infection, hemorrhage, or thrombosis, and can result in death. The limb defects range from mild (unilateral or bilateral short distal phalanges) to severe (complete absence of all toes or fingers, feet or hands, or more, often resembling an amputation). The lower extremities are almost always more severely affected than the upper extremities. Additional major features frequently include cardiovascular malformations/dysfunction (23%), brain anomalies, and less frequently renal, liver, and eye anomalies.</Attribute>
                <XRef ID="NBK355754" DB="GeneReviews" />
              </AttributeSet>
              <XRef ID="974" DB="Orphanet" />
              <XRef ID="C3809092" DB="MedGen" />
              <XRef ID="MONDO:0014124" DB="MONDO" />
              <XRef Type="MIM" ID="615297" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9837466" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-29" DateCreated="2024-06-29">
        <ClinVarSubmissionID localKey="NC_000003.11:g.(?_69058895)_(69061253_?)del|MedGen:C3809092" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005066339" DateUpdated="2024-06-29" DateCreated="2024-06-29" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23522784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23860037</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with EOGT-related conditions. This variant results in the deletion of exon 3 and part of exon 4 of the EOGT gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EOGT are known to be pathogenic (PMID: 23522784, 23860037).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
              <MethodAttribute>
                <Attribute Type="StructVarMethodType">Read depth</Attribute>
              </MethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.(?_69058895)_(69061253_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3809092" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14505471</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9837466" TraitType="Disease" MappingType="XRef" MappingValue="C3809092" MappingRef="MedGen">
        <MedGen CUI="C3809092" Name="Adams-Oliver syndrome 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

